TheStreet Quant Ratings rates Nuance Communications Inc. (NASDAQ:NUAN) as a hold. The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. Nuance Communications Inc. (NASDAQ:NUAN) shares after opening at $14.93 on last trade day and at the end of the day closed at $15.95. Company price to sales ratio in past twelve months was calculated as 2.70 and price to cash ratio as 6.48. Nuance Communications Inc. (NASDAQ:NUAN) showed a positive weekly performance of 4.38%.
SeaWorld Entertainment Inc (NYSE:SEAS), which has been under attack over its treatment of killer whales, reported a slight drop in attendance in 2013 but collected record revenue from higher ticket prices and in-park spending. The net income dropped primarily due to higher operating expenses and a onetime fee to end a consulting contract, according to financial records. SeaWorld Entertainment Inc (NYSE:SEAS) shares advanced 3.33% in last trading session and ended the day on $32.56. SEAS return on equity ratio is recorded as 10.00% and its return on assets is 2.10%.
TheStreet Quant Ratings rates Vipshop Holdings Ltd – ADR (NYSE:VIPS) as a hold. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. Vipshop Holdings Ltd – ADR (NYSE:VIPS) shares moved up 1.08% in last trading session and was closed at $150.79, while trading in range of $141.00 – $154.31. Vipshop Holdings Ltd – ADR (NYSE:VIPS) year to date (YTD) performance is 80.20%.
Puma Biotechnology Inc (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:45 a.m. EDT on Wednesday, March 19, at the Bank of America Merrill Lynch 2014 Smid Cap Conference. The conference will be held at The Ritz-Carlton, Boston Common. Puma Biotechnology Inc (NYSE:PBYI) weekly performance is 2.25%. On last trading day company shares ended up $114.86. Puma Biotechnology Inc (NYSE:PBYI) distance from 50-day simple moving average (SMA50) is -3.03%. Analysts mean target price for the company is $139.33.